Apg Asset Management N.V. Taro Pharmaceutical Industries LTD Transaction History

Apg Asset Management N.V.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$54.4 - $73.42 $4.15 Million - $5.6 Million	-76,214 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$54.41 - $68.2 $276,892 - $347,069	-5,089 Reduced 6.26%	76,214 $3.57 Million
Q2 2020 Aug 14, 2020	SELL	$61.66 - $70.16 $3.08 Million - $3.5 Million	-49,900 Reduced 38.03%	81,303 $4.81 Million
Q1 2020 May 15, 2020	SELL	$59.35 - $88.73 $5.2 Million - $7.77 Million	-87,597 Reduced 40.04%	131,203 $8.03 Million
Q1 2020 May 14, 2020	BUY	$59.35 - $88.73 $801,225 - $1.2 Million	13,500 Added 6.58%	218,800 $21.1 Million
Q4 2019 Feb 13, 2020	SELL	$74.18 - $97.92 $81,598 - $107,712	-1,100 Reduced 0.53%	205,300 $16.1 Million
Q3 2019 Nov 08, 2019	SELL	$75.36 - $86.57 $316,512 - $363,594	-4,200 Reduced 1.99%	206,400 $14.3 Million
Q2 2019 Aug 13, 2019	SELL	$83.92 - $108.88 $688,144 - $892,816	-8,200 Reduced 3.75%	210,600 $15.8 Million
Q1 2019 May 14, 2019	SELL	$85.97 - $108.09 $636,178 - $799,866	-7,400 Reduced 3.27%	218,800 $21.1 Million
Q4 2017 Jan 24, 2018	BUY	$104.5 - $126.38 $282,150 - $341,226	2,700 Added 1.21%	226,200 $19.7 Million
Q3 2017 Oct 19, 2017	BUY	$97.26 - $116.2 $21.7 Million - $26 Million	223,500	223,500 $25.2 Million

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.